3Dbiology_Banner

Q&A with Dr. Sergio Rutella: Multi-analyte studies in acute myeloid leukemia

Sergio Rutella, M.D., Ph.D. FRCPath is a Professor of Cancer Immunotherapy at the John van Geest Cancer Research Centre at Nottingham Trent University. His research focuses on acute myeloid leukemia (AML), an aggressive form of cancer that originates in the...

/ December 14, 2017
nsolver-background-blog

Top 5 reasons why nSolver 4.0 and Advanced Analysis 2.0 will change your (data analysis) life

Your data doesn’t fit in a box. Gone are the days of assay-specific data analysis. nSolver 4.0 is analyte focused and less assay restricted. This means that any combination of analytes you can dream up is supported. Customize your experiment...

/ November 22, 2017
3Dbiology_Banner

Q&A with Dr. David Coffey, FHCRC: Multi-analyte studies in multiple myeloma and lymphoma

David Coffey, MD, is a physician scientist with the Fred Hutchinson Cancer Research Center in Seattle, Washington. When he’s not treating patients, he’s in the lab researching blood cancers such as multiple myeloma and lymphoma. His research centers on the...

/ November 16, 2017
3Dbiology_Banner

Moving Toward the Clinic- Leveraging Xenograft Models for Preclinical Anti-Cancer Studies

The use of cancer cell lines for in vitro studies of anti-cancer agents remains a primary component of preclinical drug development. These studies, however, struggle with significant pitfalls given the unique biology of cancer cell lines and the artificial assay...

/ November 2, 2017
nsolver-background-blog

Welcome to the nSolver™ Software Tech Blog!

We love that you’re here. Here’s why you’re going to love it, too: Fun-size articles on nSolver & Advanced Analysis. In between scientific papers, grant applications, and your other lengthy reading obligations, our blog post will be a fresh change...

/ October 25, 2017